Ralph A. Schmid

12.3k total citations · 2 hit papers
296 papers, 8.7k citations indexed

About

Ralph A. Schmid is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Ralph A. Schmid has authored 296 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 137 papers in Pulmonary and Respiratory Medicine, 117 papers in Surgery and 54 papers in Molecular Biology. Recurrent topics in Ralph A. Schmid's work include Transplantation: Methods and Outcomes (35 papers), Lung Cancer Diagnosis and Treatment (35 papers) and Pleural and Pulmonary Diseases (33 papers). Ralph A. Schmid is often cited by papers focused on Transplantation: Methods and Outcomes (35 papers), Lung Cancer Diagnosis and Treatment (35 papers) and Pleural and Pulmonary Diseases (33 papers). Ralph A. Schmid collaborates with scholars based in Switzerland, Germany and United States. Ralph A. Schmid's co-authors include Ben A. Barres, Martin Raff, Gregor J. Kocher, Walter Weder, Ren‐Wang Peng, Thomas Geiser, Olivier T. Guenat, Sean R. R. Hall, Mathias Gugger and Uz Stammberger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Ralph A. Schmid

287 papers receiving 8.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multiple extracellular signals are required for long-term oligodendrocyte survival

1993 616 citations Ralph A. Schmid et al. profile →
Second-generation lung-on-a-chip with an array of stretchable alveoli made with a biological membrane

2021 230 citations Nina Hobi, Ralph A. Schmid et al. profile →

Peers

Countries citing papers authored by Ralph A. Schmid

Since Specialization

Citations

This map shows the geographic impact of Ralph A. Schmid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph A. Schmid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph A. Schmid more than expected).

Fields of papers citing papers by Ralph A. Schmid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph A. Schmid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph A. Schmid. The network helps show where Ralph A. Schmid may publish in the future.

Co-authorship network of co-authors of Ralph A. Schmid

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph A. Schmid. A scholar is included among the top collaborators of Ralph A. Schmid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph A. Schmid. Ralph A. Schmid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma 2025 ·EMBO Molecular Medicine ·Duo Xu, Yanyun Gao, (unknown), (unknown), Tong Hu, (unknown), Tuo Zhang, Balázs Hegedűs, Thomas M. Marti, Patrick Dorn, Shun‐Qing Liang, Ralph A. Schmid, Ren‐Wang Peng, (unknown)	0
2	Lactate dehydrogenase B noncanonically promotes ferroptosis defense in KRAS-driven lung cancer 2024 ·Cell Death and Differentiation ·Liang Zhao, (unknown), Jingyi Zhang, Nicola Zamboni, Haitang Yang, Yanyun Gao, Yang Zhang, Duo Xu, Haiqing Zhong, Geert van Geest, Rémy Bruggmann, Qinghua Zhou, Ralph A. Schmid, Thomas M. Marti, Patrick Dorn, Ren‐Wang Peng	10
3	Schedule-Dependent Treatment Increases Chemotherapy Efficacy in Malignant Pleural Mesothelioma 2022 ·International Journal of Molecular Sciences ·(unknown), (unknown), Yanyun Gao, (unknown), Ren‐Wang Peng, Ralph A. Schmid, Patrick Dorn, Thomas M. Marti	5
4	Dissecting the Immunological Profiles in NSD3-Amplified LUSC through Integrative Multi-Scale Analyses 2022 ·Cancers ·Duo Xu, (unknown), Xi Wu, Thomas M. Marti, Patrick Dorn, Ralph A. Schmid, Ren‐Wang Peng, Yongqian Shu	7
5	Robotic-Assisted Thoracoscopic Resection of the First Rib for Vascular Thoracic Outlet Syndrome: The New Gold Standard of Treatment? 2021 ·Journal of Clinical Medicine ·(unknown), (unknown), Patrick Dorn, Fabrizio Minervini, Peter Kestenholz, Hans Gelpke, Ralph A. Schmid, Gregor J. Kocher	8
6	Chaperone-Mediated Autophagy Markers LAMP2A and HSPA8 in Advanced Non-Small Cell Lung Cancer after Neoadjuvant Therapy 2021 ·Cells ·(unknown), (unknown), (unknown), Ralph A. Schmid, Mario P. Tschan, Sabina Berezowska	6
7	NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural Mesothelioma 2021 ·Cancers ·Haitang Yang, Sean R. R. Hall, Beibei Sun, Liang Zhao, Yanyun Gao, Ralph A. Schmid, Swee T. Tan, Ren‐Wang Peng, Feng Yao	28
8	CRISPR-Mediated Kinome Editing Prioritizes a Synergistic Combination Therapy for FGFR1 -Amplified Lung Cancer 2021 ·Cancer Research ·Yang Zhang, Shun‐Qing Liang, Haitang Yang, Duo Xu, Rémy Bruggmann, Yanyun Gao, (unknown), Sabina Berezowska, Sean R. R. Hall, Thomas M. Marti, Gregor J. Kocher, Qinghua Zhou, Ralph A. Schmid, Ren‐Wang Peng	22
9	Pharmacotranscriptomic Analysis Reveals Novel Drugs and Gene Networks Regulating Ferroptosis in Cancer 2020 ·Cancers ·Haitang Yang, Liang Zhao, Yanyun Gao, Feng Yao, Thomas M. Marti, Ralph A. Schmid, Ren‐Wang Peng	36
10	Pleural Fluid with Hooklets in a 7-Year-Old Boy with Severe Multisystem Cystic Echinococcosis 2020 ·American Journal of Respiratory and Critical Care Medicine ·Patrick M. Meyer Sauteur, Sasha J. Tharakan, Christa Relly, (unknown), Ralph A. Schmid, (unknown), Alexander Mœller, Ralph Gnannt, Christoph Berger, Ueli Moehrlen	1
11	Beyond DNA Repair: DNA-PKcs in Tumor Metastasis, Metabolism and Immunity 2020 ·Cancers ·Haitang Yang, Feng Yao, Thomas M. Marti, Ralph A. Schmid, Ren‐Wang Peng	29
12	Systematic Analysis of Aberrant Biochemical Networks and Potential Drug Vulnerabilities Induced by Tumor Suppressor Loss in Malignant Pleural Mesothelioma 2020 ·Cancers ·Haitang Yang, Duo Xu, Yang Zhang, Feng Yao, Heng Zhao, Ralph A. Schmid, Ren‐Wang Peng	14
13	Endoplasmic Reticulum Stress Signaling as a Therapeutic Target in Malignant Pleural Mesothelioma 2019 ·Cancers ·Duo Xu, Haitang Yang, Yang Zhang, Sabina Berezowska, Yanyun Gao, Shun‐Qing Liang, Thomas M. Marti, Sean R. R. Hall, Patrick Dorn, Gregor J. Kocher, Ralph A. Schmid, Ren‐Wang Peng	29
14	Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment 2019 ·Cancer Cell International ·Yanyun Gao, Patrick Dorn, (unknown), (unknown), Sean R. R. Hall, Ren‐Wang Peng, Ralph A. Schmid, Thomas M. Marti	30
15	Tumor Initiation Capacity and Therapy Resistance Are Differential Features of EMT-Related Subpopulations in the NSCLC Cell Line A549 2018 ·Neoplasia ·(unknown), Yanyun Gao, (unknown), Nina Hobi, Sabina Berezowska, (unknown), Laurène Froment, Stefan Weis, Ren‐Wang Peng, Rémy Bruggmann, Primo Schär, (unknown), (unknown), Patrick Dorn, Gregor J. Kocher, Carsten Riether, Adrian F. Ochsenbein, Ralph A. Schmid, Thomas M. Marti	46
16	mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer 2018 ·Oncogene ·Shun‐Qing Liang, (unknown), Sabina Berezowska, Thomas M. Marti, Duo Xu, Laurène Froment, Haitang Yang, Sean R. R. Hall, Erik Vassella, Yang Zhang, Gregor J. Kocher, (unknown), Carsten Riether, Adrian F. Ochsenbein, Ralph A. Schmid, Ren‐Wang Peng	45
17	CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives 2017 ·Respiratory Research ·Lourdes Cortes‐Dericks, Ralph A. Schmid	36
18	Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT 2016 ·BMC Cancer ·(unknown), Ren‐Wang Peng, Patrick Dorn, Laurène Froment, Ralph A. Schmid, Thomas M. Marti	40
19	The lectin-like domain of tumor necrosis factor improves lung function after rat lung transplantation—Potential role for a reduction in reactive oxygen species generation* 2010 ·Critical Care Medicine ·Jürg Hamacher, Uz Stammberger, Jérémie Roux, Sanjiv Kumar, Guang Yang, Chenling Xiong, Ralph A. Schmid, Richard M. Fakin, Trinad Chakraborty, Hamid Hossain, Jean‐François Pittet, Albrecht Wendel, Stephen M. Black, Rudolf Lucas	33
20	[Echinococcosis in Switzerland, 1926-1955]. 1958 ·PubMed ·Ralph A. Schmid	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact